The U.S. FDA has approved Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE, for adults aged 65 and older and those aged 12–64 with risk factors, marking a major step under tighter regulations.
The U.S. Food and Drug Administration has approved Moderna’s latest COVID-19 vaccine, mNEXSPIKE, for people aged 65 and above and for those aged 12 to 64 with at least one underlying risk factor, as defined by the CDC. This is the first approval following the agency’s recent tightening of vaccine requirements.
Moderna expects to distribute the updated mRNA-based vaccine during the 2025–2026 respiratory virus season. Unlike previous versions, mNEXSPIKE can be stored in regular refrigerators, simplifying distribution, particularly in low-resource settings.
“This approval adds an important tool to help protect high-risk groups,” said Moderna CEO Stéphane Bancel.
The FDA recently shifted its guidelines, requiring placebo-controlled trials for younger, healthy adults, effectively limiting new COVID-19 boosters to those at higher risk of severe disease. Regulatory tightening comes under the Department of Health and Human Services, now led by Robert F. Kennedy Jr., who has long expressed skepticism about vaccines.
Despite concerns over regulatory changes, the CDC reaffirmed that COVID vaccines remain an option for healthy children when deemed necessary by parents and doctors. Analysts say this helps maintain market stability for vaccine makers by preserving demand in core demographics.
The FDA also recently approved Novavax’s protein-based COVID vaccine Nuvaxovid, but similarly restricted its use to older and at-risk individuals. Moderna, meanwhile, is focusing on its newer mRNA pipeline to counter declining interest in its original Spikevax and lower-than-expected uptake of its RSV shot.
Trial data supporting mNEXSPIKE’s approval showed the new vaccine performed equally or better than Spikevax, particularly among adults aged 18 and older.
As the U.S. government pursues agency overhauls and budget cuts, questions remain about the long-term regulatory environment. Still, with 100 to 200 million Americans eligible for boosters under current rules, the market for COVID-19 vaccines - especially next-generation options like mNEXSPIKE - remains significant.
Secretary of State Marco Rubio told allied foreign ministers Washington will focus on sanctions and other pressure on Iran “for the time bein...
Kazakhstan is considering the Baku-Supsa pipeline as an alternative oil export route after Caspian Pipeline Consortium disruptions cost the country...
Kuwait’s Al-Sayer Group plans to export fresh and dried Afghan fruit to Kuwait and other markets while exploring broader trade and investment...
Oil prices fell after the U.S. expanded economic sanctions on Iran, as Tehran vowed to retaliate and warned it had tools to respond, raising concerns over potential disruption to regional oil supplies.
Kyiv has recently received a small number of U.S.-made Patriot interceptors capable of downing Russian ballistic missiles, Ukrainian President Volodymyr Zelenskyy has said. It comes as Britain and France pledged stronger military support for Ukraine.
Only four commodity vessels crossed the Strait of Hormuz on Sunday, following 13 transits a day earlier, as disruptions continue to restrict traffic through the key energy chokepoint.
Secretary of State Marco Rubio told allied foreign ministers Washington will focus on sanctions and other pressure on Iran “for the time being”, Axios reports. Meanwhile, Iran and Oman have resumed talks on a temporary shipping route through the Strait of Hormuz.
Russia and Ukraine have exchanged 10 prisoners of war each in Belarus, Moscow's Human Rights Commissioner, Yana Lantratova, has said.
Australia has confirmed its first case of H5N1 bird flu in a mammal after the virus was detected in a dead long-nosed fur seal in South Australia, authorities said.
Malaysia is facing a sharp rise in dengue infections, with the capital Kuala Lumpur and the wider Klang Valley emerging as the main centres of concern.
The Democratic Republic of the Congo’s Ebola outbreak has surpassed 5,000 confirmed cases, with the death toll reaching 2,378, according to the latest government data.
The Democratic Republic of Congo says the number of confirmed Ebola cases has risen to more than 5,000, with more than 2,300 deaths. Delayed detection, weak surveillance, funding shortages and conflict have allowed the virus to spread faster than in any previous epidemic at the same stage.
Australia warned on Monday (3 August) of a wider spread of H5N1 bird flu after its first confirmed mass mortality event among seabirds killed about 50 greater crested terns off the coast of South Australia, south of Adelaide.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment